Company Filing History:
Years Active: 2016
Title: The Innovations of Bernhard Hubert Geierstranger
Introduction: Bernhard Hubert Geierstranger is a notable inventor based in Solana Beach, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work focuses on addressing metabolic conditions through innovative solutions.
Latest Patents: Geierstranger holds a patent for "Dual function fibroblast growth factor 21 proteins." This invention relates to dual function fusion proteins comprising fibroblast growth factor 21 (FGF21) and Exenatide, Exendin-4, or GLP-1. The patent also discloses methods for treating FGF21-associated disorders, GLP-1-associated disorders, and Exendin-4-associated disorders, including various metabolic conditions. He has 1 patent to his name.
Career Highlights: Throughout his career, Geierstranger has been associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations: Geierstranger has collaborated with esteemed colleagues such as Brian R. Boettcher and Shari Lynn Caplan. These partnerships have fostered innovation and advancement in their respective fields.
Conclusion: Bernhard Hubert Geierstranger's contributions to biotechnology and his innovative patent demonstrate his commitment to improving health outcomes through scientific advancements. His work continues to influence the development of therapies for metabolic disorders.